CMax
Business Services · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
21-24 North Ter, Adelaide, South Austral...Phone Number
+61 870887900Website
www.cmax.com.auRevenue
$19.9 MillionIndustry
About CMax
CMax Org Chart
Is CMax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CMax had a recent Job posting/layoffs
Funding: Get notified immidiatlly once CMax has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CMax, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CMax launches new products
Check if CMax has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CMax recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at CMax
Check out if CMax is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CMax
Compare insights from companies similar to CMax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CMax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CMax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CMax.
CMax Tech Stack
A closer look at the technologies used by CMax
Most Recent Scoops
CMax News & Media
Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research
San Diego, California, April 28, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet need, has retained CMAX Clinical Research (“CMAX”) to facilitate enrollment of and drug administration to healthy volunteers for Skye’s Phase 1 study of its lead product candidate, SBI-100 Ophthalmic Emulsion (“SBI-100 OE”). This studyCytoAgents Launches Clinical Trials for GP1681, Treatment of COVID-19 Cytokine Storm
PITTSBURGH--(BUSINESS WIRE)-- #Covid19--CytoAgents, a clinical-stage biotechnology company, announced today that enrollment has started for its Phase 1 clinical trial with lead drug candidate, GP1681, for treatment of COVID-19 “cytokine storm,” clinically known as hypercytokinemia. A randomized, double-blind, placebo-controlled study to assess the safety and tolerability of GP1681 in healthy adults, the Phase 1 Trial, is being conducted in partnership with contract research organization, Novotec
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding CMax
Established in 1993, CMAX is one of Australia's largest and most experienced clinical trial centers, dedicated to supporting innovative medical research in collaboration with national and international sponsors. Located in Adelaide's Bio-Med City, the facility offers various trial durations and has conducted over 600 early-phase clinical trials, in... Read More
